Resource Center
National Brain Tumor Society
National Brain Tumor Society (NBTS) unrelentingly invests in, mobilizes, and unites the brain tumor community to discover a cure, deliver effective treatments, and advocate for patients and caregivers. Every brain tumor experience is unique, and every patient deserves a better chance at survival, a better chance at an adequate quality of life, and the best information available to understand options and make choices for their treatment.
Brain Tumor Foundation
The Brain Tumor Foundation (BTF) guides and supports patients and families during the turbulent times when their lives are touched by a brain tumor. Living with a brain tumor is difficult both for the patient and their family. A good support system can help give you the strength you need to get through it.
Head for the Cure
Honoring those we've lost, patients & survivors, caregivers, and healthcare personnel at our 5K run/walk events and beyond. From diagnosis to daily living, Head for the Cure provides trusted information and support to help you understand, manage, and cope with a brain tumor.
StacheStrong
StacheStrong is a 501(c)3 nonprofit devoted to raising funds and awareness for brain cancer research. Defeating brain cancer and improving the quality of patients’ lives is our daily focus. With the help of our supporters, we’ve funded over $7,000,000 of brain cancer research to date. Our organization has become a beacon of hope for countless individuals and families afflicted with this disease, and we serve as an ardent advocate for all those impacted by brain cancer.
Epilepsy Foundation
Improving the lives of people affected by epilepsy through education, advocacy, research, and connection.
RealLIST Startups 2023: Meet Pittsburgh’s most promising young tech companies
Pittsburgh, it’s January — which means it’s time for a new RealLIST. From robotics to life sciences to social enterprises, these 10 startups (plus 10 runners-up) are poised for growth in the new year.
30 Under 30: Meet Max Sims, MindTrace Technologies
Sims, one of the Pittsburg Times' 2022 30 Under 30 winners, is co-founder and CEO of MindTrace Technologies.
Q&A with MindTrace Founders
Join ius for Q&A with MindTrace Founders, Max Sims, Brad Mahon, and Hugo Angulo.
MindTrace Is Improving Brain Surgery Outcomes Through Behavioral Mapping
Co-founders Brad Mahon, Max Sims, and Hugo Angulo are building tools that help brain surgeons understand how procedures will impact a patient’s core functions, like speech and memory. It’s a new approach that bridges cognition and anatomy at the point of care.
AlphaLab Health’s second accelerator is growing these 6 health and medtech startups
AlphaLab Health — one of three startup accelerators run by Innovation Works — announced its second cohort of companies this week. The six month-program, which was originally formed through a partnership with Allegheny Health Network, focuses on growing companies in the life sciences or healthcare industries by providing them with resources for product development, customer insights and industry mentorship.
MindTrace’s work on brain surgery tops class at Pittsburgh Life Sciences Accelerator
MindTrace, a Carnegie Mellon University spinoff company, has just been rewarded for its work in helping brain surgeons predict what the cognitive outcome is going to be for a patient before the first cut is made.
LifeX Labs, Pittsburgh Life Sciences Greenhouse Collaborate on Life Sciences Accelerator
LifeX Labs and Pittsburgh Life Sciences Greenhouse (PLSG) have co-sponsored a Life Sciences Accelerator. Announcing MindTrace as First Prize Winner of Spring 2021 Cohort.
Program For Translational Brain Mapping
Our mission is to apply the latest innovations in personalized brain mapping to ensure the best outcome for our patients and to advance the scientific study of the human brain.
Neurosurgeons Are Really Good at Removing Brain Tumors, and They’re About To Get Even Better
In a leap for personalized medicine, CMU scientists have discovered a simple and valuable way to improve brain cancer surgeries. When removing cancerous tissue in the brain, neurosurgeons often use “awake brain mapping” to minimize the risk of causing unintended disruptions to a patient’s quality of life while removing as much tumor as possible. This practice, which has been used for decades, involves waking a patient up mid-surgery to test their neurocognitive functions in real time by stimulating the brain surface and assessing for functional changes.
A Smarter Map for the Brain: Surgeons Pioneer Next-Generation Navigation
The University of Rochester Medical Center (URMC) has begun using a new surgical decision-support technology called MindTrace, marking a significant advance in how brain surgeons plan and perform complex tumor operations. Developed from decades of neuroscience and neurosurgical research, MindTrace helps surgical teams predict how different surgical approaches might affect speech, movement, and other vital functions, helping preserve quality of life after surgery.
Causal parametric language mapping with electrical stimulation during awake neurosurgery
Functional mapping with direct electrical stimulation (DES) is widely used during awake neurosurgery to generate causal evidence about person-specific neuroanatomical organization. According to a long-standing clinical and scientific paradigm, if the application of DES to a given brain region does not result in performance errors, that site is considered to be uninvolved in the task.
Case Study: Mapping music ability during awake brain surgery
In 2015 Dan, a 26 year old musician and music teacher started to experience auditory hallucinations. An MRI scan revealed a tumor in his right posterior temporal lobe, directly adjacent to a region (superior temporal gyrus) known to be involved in music processing and analysis of complex auditory stimuli.
Translational Brain Mapping
Translational Brain Mapping at the University of Rochester Medical Center: Preserving the Mind Through Personalized Brain Mapping. This video provides an overview of a multi-modal brain mapping program designed to identify regions of the brain that support critical cognitive functions in individual neurosurgery patients.
Which new startups will bring the next generation of technology to life
Early this year, Richard King Mellon Foundation announced funding for 16 startups, investing a total of $3.39 million in winners of its pitch competition. We wanted to spotlight a small sampling of those companies and the new technologies they’re bringing to life.
Pioneer Consortium
The PIONEER Consortium (Personalized Interventions and Outcomes in Neurosurgical Oncology Research Consortium) is a global, collaborative reserach platform that was established in 2019 to address the criticial lack of prospective, multicenter evidence in surgical neuro-oncology.
3518 Fifth Avenue, First Floor
Pittsburgh, Pennsylvania 15213
